• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.26% Nasdaq Up 0.23%

    Clovis Oncology, Inc. (CLVS)

    -NasdaqGS
    81.96 Down 0.13(0.16%) May 4, 4:00PM EDT
    |After Hours : 81.95 Down 0.01 (0.01%) May 4, 7:57PM EDT
    Add to Portfolio
    Prev Close:82.09
    Open:81.84
    Bid:N/A
    Ask:81.95 x 100
    1y Target Est:96.56
    Beta:1.6
    Next Earnings Date: 6-May-15CLVS Earnings announcement
    Day's Range:81.24 - 85.91
    52wk Range:35.33 - 94.88
    Volume:785,840
    Avg Vol (3m):597,520
    Market Cap:2.79B
    P/E (ttm):N/A
    EPS (ttm):-4.72
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CLVS

    Comparison

    Symbol% ChgMkt Cap
    CLVSDown 0.16%2.79B
    IMMUUp 0.26%360.47M
    LRUSF 0.00%N/A
    THLDDown 0.85%248.95M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):204.95
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-8.19
    Quarterly EPS Est (Mar-15) :-1.82
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback